Shilajit Safety, Side Effects and Contraindications: What the Evidence Shows

Shilajit has moved from traditional Ayurvedic practice onto mainstream supplement shelves, and people increasingly ask the same question before taking it: is it safe? The honest answer is neither “completely safe” nor “dangerous.” Small human trials of purified material have reported good tolerability over weeks to a few months, while unprocessed or untested products can carry contaminants such as heavy metals and microbes. Long-term data and data in special populations are limited.

This guide separates three things that are often mixed together: adverse events that have actually been documented, risks that are only theoretical, and hazards that come from contamination rather than from the substance itself. You will see what the evidence can and cannot tell us, who should be cautious, which warning signs matter and what to check before buying.

Educational use only. This article does not replace individualized medical advice. Speak with a qualified clinician or pharmacist before using any supplement, especially if you are pregnant, have a medical condition or take medicines.

Shilajit Safety Summary: What the Evidence Shows

• Documented in humans: A handful of small trials, each with roughly 60 to 100 participants and lasting 8 to 12 weeks, used purified or processed material and described it as well tolerated (Biswas et al., 2010; Pandit et al., 2016; Keller et al., 2019). No reliable incidence figures for side effects exist.
• Contamination-related hazard: The clearest safety concern is raw, unpurified or poorly tested material, which can contain heavy metals, fungi and other contaminants (Stohs, 2014).
• Theoretical concerns: Possible hormonal, metabolic, iron-related and interaction effects have been proposed, but they are not established in people.
• Major gaps: There is little data on long-term use, pregnancy, breastfeeding, children, older adults and drug interactions.
• Bottom line: Safety depends on the product, dose, duration and the person taking it. Nothing in the current evidence supports calling it universally safe or universally dangerous.

Common Reported Shilajit Side Effects

Because the available trials were small and did not systematically report event rates, there are no trustworthy percentages for how often side effects occur. In the published trials of purified or processed material, the authors described the supplements as well tolerated (Biswas et al., 2010; Pandit et al., 2016).

Symptoms that appear in reviews, product information and consumer reports, and that should be considered possible rather than proven, include:

• Digestive upset: nausea, stomach discomfort, loose stools or heartburn
• Headache or dizziness
• Skin reactions: itching or rash, which may reflect sensitivity to the material or to other ingredients in a formula

These effects are usually described as mild and short-lived, but “usually mild” is not a guarantee. Digestive symptoms are more likely with larger doses, an empty stomach or a poorly made product. If symptoms appear, stopping the supplement and speaking with a clinician is a sensible step.

Less Common and Serious Reports

Serious adverse events attributed to properly purified, tested material are rarely described in the peer-reviewed literature. That scarcity is not proof of safety. It may reflect under-reporting, limited use in studied groups, small trials that cannot detect rare events, and the absence of a formal surveillance system for most supplements.

Where serious harm has been documented in the wider Ayurvedic product category, it has usually been linked to contamination or deliberate metal content, not to purified plant or humic material. For example, a US public health report described lead poisoning in people using Ayurvedic medicines (CDC, 2004), and two surveys of Ayurvedic products sold online found that a notable share contained detectable lead, mercury or arsenic (Saper et al., 2004; Saper et al., 2008). These studies were not specific to Shilajit, so they should be read as a warning about product quality in this market, not as a finding about the substance itself.

One documented physiological effect deserves attention. In a trial of 96 healthy men aged 45 to 55, purified material at 250 mg twice daily for 90 days was associated with higher total testosterone (Pandit et al., 2016). That is a pharmacological effect, which is why hormone-related conditions appear in the precautions below.

Dose-Related Safety

There is no officially established upper intake level, and no regulator has published a safe daily limit. Doses used in human research include:

Study	Material	Dose	Duration
Biswas et al., 2010	Processed	100 mg twice daily	90 days
Pandit et al., 2016	Purified	250 mg twice daily	90 days
Keller et al., 2019	Shilajit supplement	500 mg daily	8 weeks

Three practical points follow from this:

1. Studied doses are not safe limits. They show what was tested, not what is safe above that range.
2. Contaminant exposure scales with dose. A product with 1 mg/kg of lead delivers about 0.5 µg in a 500 mg serving, and doubling the dose doubles the intake. For reference, the ICH Q3D guideline sets a daily oral limit of roughly 5 µg of lead for medicines.
3. Resin dosing is imprecise. “Pea-sized” or “thumbnail” portions vary widely, so it is easy to take more than intended. Products with a stated milligram amount are easier to dose responsibly.

More is not safer. Follow the label or a clinician’s advice rather than traditional recipes found online.

Duration of Use in Human Trials

The controlled human studies identified in this review lasted about 8 to 12 weeks. The trials by Biswas and Pandit each ran for 90 days, and Keller and colleagues used an 8-week protocol. No randomised trials of multi-year use are available.

Traditional use over long periods exists in Ayurvedic practice, but traditional use is not the same as monitored clinical safety data. Claims that the material must be cycled on and off, or that it is safe for years, are not supported by controlled evidence. Anyone planning extended use should discuss monitoring with a clinician, particularly if the product has not been tested for heavy metals.

Shilajit Contraindications and Who Should Be Cautious

No major regulator or pharmacopoeia lists formal contraindications for oral supplements of this kind that are supported by robust clinical data. The situations below are precautions, many based on theoretical reasoning, and each is labelled by how well it is supported.

• Known allergy or hypersensitivity to the product or any ingredient in the formula (strong logic, general principle).
• Pregnancy and breastfeeding: insufficient safety data, so avoidance is prudent unless a clinician advises otherwise.
• Children and adolescents: no controlled safety data in this group.
• Iron overload disorders such as hemochromatosis: the material contains minerals, including iron, so people who must limit iron should seek medical advice (theoretical, mineral content varies by batch).
• Hormone-sensitive conditions or testosterone therapy: because testosterone increased in one trial, people with prostate disease, hormone-sensitive cancers or those using hormone treatments should ask their clinician (theoretical, based on limited data).
• Diabetes treated with glucose-lowering drugs: some laboratory and animal studies suggest effects on glucose handling, so blood sugar monitoring may be worth discussing (theoretical).
• Autoimmune or immune-suppressed states: the substance has been described as immune-modulating in laboratory research, but human evidence is thin (theoretical).
• Kidney or liver disease: these organs are vulnerable to contaminant exposure, and data in these patients are absent.
• Before surgery: tell the surgical and anaesthesia team about all supplements.

Allergy Considerations

Well-documented allergy cases specific to this material are lacking in the literature, but allergy to a complex natural mixture is always possible. Sources of reactions can include:

• the substance itself, which is a variable mixture of humic compounds, organic acids and minerals
• fungal or other biological residues in poorly processed raw material
• other ingredients in the product, such as capsule materials, honey, soy, milk-based carriers or added herbs

Mild reactions include rash, itching and hives. Swelling of the lips or face, wheezing, throat tightness, a rapid heartbeat or faintness can signal anaphylaxis and require emergency care. Check the full ingredient list, including allergen statements, before use.

Shilajit Heavy Metal Contamination and Organ-Specific Concerns

Raw material is formed in and collected from rock and soil, so it can absorb metals from its environment. A safety review concluded that unpurified material may be contaminated with heavy metals and fungi, and recommended purified forms (Stohs, 2014). Surveys of Ayurvedic products show that metal contamination is a real quality issue in this market (Saper et al., 2004; 2008).

Organ concerns are best described as contaminant-related, not as proven toxicity of purified material:

• Kidneys: cadmium, lead and mercury accumulate in kidney tissue with chronic exposure (ATSDR toxicological profiles).
• Nervous system: lead and mercury are neurotoxic, with children and the developing fetus most vulnerable.
• Blood: lead interferes with haemoglobin synthesis and can contribute to anaemia.
• Skin and long-term cancer risk: chronic arsenic exposure is linked to skin changes and increased cancer risk.
• Liver: iron overload can injure the liver, though this relates to excess iron rather than to the supplement’s effects in healthy people.

For purified material itself, animal toxicology studies summarised in reviews reported low toxicity at the doses tested, and standard genotoxicity assays were reported as negative (Stohs, 2014). Animal findings do not translate directly into human safety, and reliable evidence of organ toxicity from purified oral use in humans is lacking. Lack of evidence is not evidence of absence.

Purified Shilajit Safety: Why Purification and Independent Testing Matter

Purification, whether through traditional shodhana or modern filtration, removes insoluble debris and can reduce some contaminants. It does not guarantee low metals, because soluble metals may remain, nor does it prove that microbial counts are acceptable. Two safeguards are needed together.

1. Batch-specific testing. Ask for a certificate of analysis that matches the lot number and shows numerical results for lead, arsenic, cadmium and mercury (usually by ICP-MS), plus microbial counts and absence of pathogens such as E. coli and Salmonella. Results should be compared with limits per daily dose, for example those in ICH Q3D or USP <2232>.

2. Independent, accredited laboratories. A laboratory working to ISO/IEC 17025 with the relevant tests in its scope is more reliable than an in-house report with no verifiable source. For a detailed buyer’s checklist, see our guide on how to choose a high-quality product.

A certificate shows what one sample contained. It does not prove that a product is effective or safe for every individual.

Shilajit Risks: Documented, Contamination-Related and Theoretical

Documented in human trials

Only a few effects are documented. Trials of purified or processed material reported good tolerability, and one reported increased total testosterone (Pandit et al., 2016). No rates of specific adverse events can be derived, because the studies were not designed to estimate them.

Contamination-related hazards

These arise from product quality: heavy metals, microbial or fungal contamination, adulteration with undeclared ingredients, and inaccurate labelling of dose. They are well supported as general risks for unregulated natural products and are specifically noted for raw material (Stohs, 2014).

Theoretical risks

These are plausible but unconfirmed in people:

• hormonal effects in people with hormone-sensitive conditions
• changes in blood sugar when combined with diabetes medicines
• additive effects with other supplements that influence immunity or hormones
• mineral interactions, for example affecting how iron or other minerals are handled

No formal drug-interaction studies are available. Anyone taking prescription medicines should ask a pharmacist to review the combination.

Pregnancy, Breastfeeding, Children and Older Adults

Pregnancy and breastfeeding. There are no adequate human safety studies, and the potential exposure of a fetus or infant to heavy metals makes untested products a particular concern. The cautious approach is to avoid it unless a clinician approves.

Children and adolescents. Controlled safety data are lacking, and children are more sensitive to lead and other metals. Use should be guided by a paediatric clinician if considered at all.

Older adults. The trials identified enrolled mainly adult men, with the best-known study including participants aged 45 to 55. Data for people over 65 are limited. Older adults are more likely to take multiple medicines and to have reduced kidney function, both of which make a pharmacist or physician review worthwhile.

People with chronic disease. Those with kidney, liver, heart, hormone-related or autoimmune conditions should seek individualised advice, since none of these groups has been studied adequately.

When to Stop Use and Seek Medical Care

Stop taking it and contact a healthcare professional if you notice:

• persistent nausea, vomiting, diarrhoea or abdominal pain
• a new rash, itching or hives
• unusual headache, dizziness or fainting
• palpitations or chest discomfort
• yellowing of the skin or eyes, or dark urine
• numbness, tingling, tremor, confusion or unexplained fatigue, which can be features of metal toxicity
• shakiness, sweating or confusion in a person with diabetes, which may signal low blood sugar
• any new or unexpected symptom that began after starting the product

Seek emergency care immediately (for example 112 in India or 911 in the United States) for swelling of the face or throat, difficulty breathing, severe chest pain, fainting or sudden confusion. A poison control centre can advise if you suspect contamination or an overdose.

Keep the packaging and batch number, and consider reporting the event. In the United States, adverse events can be reported to FDA MedWatch. In India, reports can be made through the Pharmacovigilance Programme of India or relevant Ayush channels. Reports help regulators detect patterns.

Safety Evidence Quality

The human evidence is limited in several ways:

• Small samples: trials involved roughly 60 to 100 participants, too few to detect uncommon events.
• Short follow-up: observation periods of 8 to 12 weeks cannot reveal long-term effects.
• Narrow populations: most participants were healthy adult men, and women, older adults and people with medical conditions are under-represented.
• Product differences: trials used specific purified or processed extracts, so results may not apply to other products, raw resins or different doses.
• Possible commercial involvement: some trials tested proprietary extracts, so funding and author disclosures should be checked in each paper.
• Safety as a secondary outcome: trials were designed to measure benefits, with limited systematic adverse-event monitoring.
• No post-marketing surveillance data are available that would give real-world event rates.

Overall, the certainty of the safety evidence is low to moderate for short-term use of well-characterised purified material in healthy adults, and low or very low for everything else.

Long-Term Safety Gaps

Important unanswered questions include:

• the effects of continuous use over years, including cumulative exposure to trace metals
• effects on hormones and the reproductive system with long-term use, in men and women
• effects on liver, kidney and thyroid function in routine monitoring
• formal interactions with common medicines such as diabetes drugs, blood pressure medicines, hormone therapies and immunosuppressants
• safety in pregnancy, lactation, childhood and advanced age
• dose–response relationships and any upper limit
• differences between raw, purified and standardised products

Until these gaps are filled, a precautionary approach is reasonable.

Adverse-Effect Evidence Table

Concern	Type of evidence	What is known	Main limitation
Mild digestive or skin symptoms	Trial reports and general product reports	Described as uncommon and mild; trials reported good tolerability	No incidence data; small trials
Raised testosterone	Human trial (n = 96)	Increase in total testosterone at 250 mg twice daily for 90 days	Single trial; clinical consequences not assessed
Heavy metals in raw material	Review and product surveys	Raw material may be contaminated; Ayurvedic products show metal contamination	Surveys not specific to this substance
Organ toxicity of purified material	Animal studies and reviews	Low toxicity reported at tested doses; genotoxicity tests negative	Animal data; human evidence lacking
Serious events in humans	Case reports and public health reports	Documented mainly for contaminated Ayurvedic products, not purified material	Under-reporting; no surveillance system
Interactions with drugs	Theoretical	No formal studies	Unknown
Pregnancy, children, older adults	Absent or very limited	Insufficient data	Avoidance advised unless approved by a clinician

Precautions Checklist

• I have discussed use with a clinician or pharmacist if I am pregnant, breastfeeding, taking medicines or have a medical condition.
• The product states the material form (raw or purified) and a dose in milligrams.
• I have a batch-specific certificate of analysis from an independent, accredited laboratory.
• The report gives numerical results for lead, arsenic, cadmium and mercury, and microbial testing.
• The label lists all ingredients and allergens.
• I am not taking raw, untested material.
• I am starting at the labelled dose and not exceeding it.
• I know which symptoms mean I should stop and seek care.
• I have kept the packaging and batch number.
• I have told my doctor about this supplement before tests or procedures.

Frequently Asked Questions

Is Shilajit safe to take every day?

Small trials used daily doses for 8 to 12 weeks and reported good tolerability, but no long-term studies exist. Safety depends on product quality, dose and individual health. A clinician can advise if daily use suits you.

What are the most common side effects?

Reported effects are mild digestive upset, headache and skin reactions, but no reliable rates exist. Serious effects have mainly been linked to contaminated products in the broader Ayurvedic market.

Can it cause heavy metal poisoning?

Raw or untested material can contain heavy metals, so contamination is a real risk. Purified products with batch-specific test results lower that risk, though no certificate removes it completely.

Who should avoid it?

People who are pregnant or breastfeeding, children, and anyone with a known allergy should avoid it unless a clinician says otherwise. People with iron overload, hormone-sensitive conditions, diabetes treated with medicines or serious kidney or liver disease should seek individual advice first.

Does it interact with medicines?

No formal interaction studies are available. Theoretical concerns include diabetes drugs, hormone treatments and immune-modulating medicines. Ask a pharmacist to review your list.

Is purified safer than raw?

Purified material is generally considered preferable because raw material may contain debris, microbes and metals. Purification is not a guarantee, so final-product testing still matters.

Can I take it with other supplements?

There is little data. Combining several supplements, especially those that affect hormones or blood sugar, adds uncertainty, so disclose everything you take to a healthcare professional.

How do I report a problem?

Stop use, seek care if needed and keep the packaging. In the United States, report to FDA MedWatch. In India, use the Pharmacovigilance Programme of India or Ayush channels.

References

1. Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytother Res. 2014;28(4):475–479.
2. Wilson E, Rajamanickam GV, Dubey GP, et al. Review on shilajit used in traditional Indian medicine. J Ethnopharmacol. 2011;136(1):1–9.
3. Biswas TK, Pandit S, Mondal S, et al. Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia. 2010;42(1):48–56.
4. Pandit S, Biswas S, Jana U, et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570–575.
5. Keller JL, Housh TJ, Hill EC, et al. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. J Int Soc Sports Nutr. 2019;16:3.
6. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of Ayurvedic herbal medicine products. JAMA. 2004;292(23):2868–2873.
7. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915–923.
8. Centers for Disease Control and Prevention. Lead poisoning associated with Ayurvedic medications—five states, 2000–2003. MMWR. 2004;53(26):582–584.
9. Agency for Toxic Substances and Disease Registry. Toxicological profiles for lead, arsenic, cadmium and mercury. https://www.atsdr.cdc.gov
10. International Council for Harmonisation. ICH Q3D Guideline for Elemental Impurities. https://www.ich.org
11. United States Pharmacopeia. General chapters <2232> Elemental Contaminants in Dietary Supplements and <2023> Microbiological Attributes of Nonsterile Nutritional and Dietary Supplements. https://www.usp.org
12. World Health Organization. Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. Geneva: WHO; 2007.
13. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
14. Indian Pharmacopoeia Commission. Pharmacovigilance Programme of India. https://ipc.gov.in
15. National Institutes of Health, Office of Dietary Supplements. Dietary Supplements: What You Need To Know. https://ods.od.nih.gov/factsheets/WYNTK-Consumer/